HEADER RNA BINDING PROTEIN/INHIBITOR 28-APR-20 7BZJ TITLE THE DISCOVERY OF BENZHYDROL-OXABOROLE HYBRID DERIVATIVES AS LEUCYL- TITLE 2 TRNA SYNTHETASE INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: LEUCINE--TRNA LIGASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: LEUCYL-TRNA SYNTHETASE,LEURS; COMPND 5 EC: 6.1.1.4; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STREPTOCOCCUS PNEUMONIAE (STRAIN ATCC 700669 / SOURCE 3 SPAIN 23F-1); SOURCE 4 ORGANISM_TAXID: 561276; SOURCE 5 STRAIN: ATCC 700669 / SPAIN 23F-1; SOURCE 6 GENE: LEUS, SPN23F02440; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS LEUCYL-TRNA SYNTHETASE, PNEUMONIA, RNA BINDING PROTEIN-INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR R.J.LIU,H.LI,E.D.WANG,H.ZHOU REVDAT 3 29-NOV-23 7BZJ 1 REMARK REVDAT 2 03-FEB-21 7BZJ 1 JRNL REVDAT 1 09-DEC-20 7BZJ 0 JRNL AUTH G.HAO,H.LI,F.YANG,D.DONG,Z.LI,Y.DING,W.PAN,E.WANG,R.LIU, JRNL AUTH 2 H.ZHOU JRNL TITL DISCOVERY OF BENZHYDROL-OXABOROLE DERIVATIVES AS JRNL TITL 2 STREPTOCOCCUS PNEUMONIAE LEUCYL-TRNA SYNTHETASE INHIBITORS. JRNL REF BIOORG.MED.CHEM. V. 29 15871 2021 JRNL REFN ESSN 1464-3391 JRNL PMID 33221064 JRNL DOI 10.1016/J.BMC.2020.115871 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX V1.18 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 31.40 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 21233 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.189 REMARK 3 R VALUE (WORKING SET) : 0.188 REMARK 3 FREE R VALUE : 0.217 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.140 REMARK 3 FREE R VALUE TEST SET COUNT : 1092 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 31.4000 - 4.0000 0.99 2716 133 0.1768 0.1817 REMARK 3 2 4.0000 - 3.1800 1.00 2569 133 0.1628 0.1959 REMARK 3 3 3.1800 - 2.7800 1.00 2523 137 0.1992 0.2254 REMARK 3 4 2.7800 - 2.5200 1.00 2478 143 0.1988 0.2067 REMARK 3 5 2.5200 - 2.3400 1.00 2497 128 0.1996 0.2956 REMARK 3 6 2.3400 - 2.2000 1.00 2436 165 0.2036 0.2419 REMARK 3 7 2.2000 - 2.0900 1.00 2460 116 0.2137 0.2578 REMARK 3 8 2.0900 - 2.0000 1.00 2462 137 0.2301 0.2750 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.230 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.000 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.22 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7BZJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 07-MAY-20. REMARK 100 THE DEPOSITION ID IS D_1300016784. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-MAR-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL19U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9785 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21319 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 34.20 REMARK 200 R MERGE (I) : 0.19600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.03 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 21.80 REMARK 200 R MERGE FOR SHELL (I) : 1.46200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 4K48 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 65.26 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.54 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M BIS-TRIS (PH5.5), 2.1M AMMONIUM REMARK 280 SULFATE, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 7555 Y,X,-Z+1/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+2/3 REMARK 290 10555 -Y,-X,-Z+5/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 45.17600 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 90.35200 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 67.76400 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 112.94000 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 22.58800 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 45.17600 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 90.35200 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 112.94000 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 67.76400 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 22.58800 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 755 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 759 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 771 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 784 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 227 REMARK 465 LEU A 411 REMARK 465 GLU A 412 REMARK 465 HIS A 413 REMARK 465 HIS A 414 REMARK 465 HIS A 415 REMARK 465 HIS A 416 REMARK 465 HIS A 417 REMARK 465 HIS A 418 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 601 O HOH A 732 1.93 REMARK 500 O ALA A 371 O HOH A 601 2.07 REMARK 500 OD1 ASP A 282 O HOH A 602 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 NZ LYS A 403 O HOH A 601 6555 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 382 -120.22 50.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue FGX A 501 DBREF 7BZJ A 228 410 UNP B8ZKS5 SYL_STRPJ 228 410 SEQADV 7BZJ MET A 227 UNP B8ZKS5 INITIATING METHIONINE SEQADV 7BZJ SER A 399 UNP B8ZKS5 CYS 399 ENGINEERED MUTATION SEQADV 7BZJ LEU A 411 UNP B8ZKS5 EXPRESSION TAG SEQADV 7BZJ GLU A 412 UNP B8ZKS5 EXPRESSION TAG SEQADV 7BZJ HIS A 413 UNP B8ZKS5 EXPRESSION TAG SEQADV 7BZJ HIS A 414 UNP B8ZKS5 EXPRESSION TAG SEQADV 7BZJ HIS A 415 UNP B8ZKS5 EXPRESSION TAG SEQADV 7BZJ HIS A 416 UNP B8ZKS5 EXPRESSION TAG SEQADV 7BZJ HIS A 417 UNP B8ZKS5 EXPRESSION TAG SEQADV 7BZJ HIS A 418 UNP B8ZKS5 EXPRESSION TAG SEQRES 1 A 192 MET THR GLY ALA ASN VAL THR PHE LYS VAL LYS GLY THR SEQRES 2 A 192 ASP LYS GLU PHE THR VAL PHE THR THR ARG PRO ASP THR SEQRES 3 A 192 LEU PHE GLY ALA THR PHE THR VAL LEU ALA PRO GLU HIS SEQRES 4 A 192 GLU LEU VAL ASP ALA ILE THR SER SER GLU GLN ALA GLU SEQRES 5 A 192 ALA VAL ALA ASP TYR LYS HIS GLN ALA SER LEU LYS SER SEQRES 6 A 192 ASP LEU VAL ARG THR ASP LEU ALA LYS GLU LYS THR GLY SEQRES 7 A 192 VAL TRP THR GLY ALA TYR ALA ILE ASN PRO VAL ASN GLY SEQRES 8 A 192 LYS GLU MET PRO ILE TRP ILE ALA ASP TYR VAL LEU ALA SEQRES 9 A 192 SER TYR GLY THR GLY ALA VAL MET ALA VAL PRO ALA HIS SEQRES 10 A 192 ASP GLN ARG ASP TRP GLU PHE ALA LYS GLN PHE ASP LEU SEQRES 11 A 192 PRO ILE VAL GLU VAL LEU GLU GLY GLY ASN VAL GLU GLU SEQRES 12 A 192 ALA ALA TYR THR GLU ASP GLY LEU HIS VAL ASN SER ASP SEQRES 13 A 192 PHE LEU ASP GLY LEU ASN LYS GLU ASP ALA ILE ALA LYS SEQRES 14 A 192 ILE VAL ALA SER LEU GLU GLU LYS GLY CYS GLY GLN GLU SEQRES 15 A 192 LYS VAL LEU GLU HIS HIS HIS HIS HIS HIS HET FGX A 501 76 HETNAM FGX [(1~{R},5~{R},6~{S},8~{R})-8-(6-AMINOPURIN-9-YL)-4'- HETNAM 2 FGX [(~{R})-OXIDANYL-[4-(2-OXIDANYLIDENEPROPYLSULFANYL) HETNAM 3 FGX PHENYL]METHYL]SPIRO[2,4,7-TRIOXA-3- HETNAM 4 FGX BORANUIDABICYCLO[3.3.0]OCTANE-3,7'-7- HETNAM 5 FGX BORANUIDABICYCLO[4.3.0]NONA-1(6),2,4-TRIENE]-6- HETNAM 6 FGX YL]METHOXY-TRIS(OXIDANYL)PHOSPHANIUM FORMUL 2 FGX C28 H31 B N5 O9 P S FORMUL 3 HOH *190(H2 O) HELIX 1 AA1 ARG A 249 ALA A 256 5 8 HELIX 2 AA2 LEU A 267 THR A 272 1 6 HELIX 3 AA3 GLN A 276 LEU A 289 1 14 HELIX 4 AA4 SER A 291 THR A 296 1 6 HELIX 5 AA5 ASP A 344 ASP A 355 1 12 HELIX 6 AA6 SER A 381 ASP A 385 5 5 HELIX 7 AA7 ASN A 388 GLY A 404 1 17 SHEET 1 AA1 6 GLU A 242 THR A 247 0 SHEET 2 AA1 6 GLY A 229 VAL A 236 -1 N PHE A 234 O PHE A 243 SHEET 3 AA1 6 VAL A 305 ILE A 312 -1 O ILE A 312 N LYS A 235 SHEET 4 AA1 6 GLU A 319 ILE A 324 -1 O MET A 320 N ALA A 311 SHEET 5 AA1 6 PHE A 258 LEU A 261 1 N LEU A 261 O TRP A 323 SHEET 6 AA1 6 ALA A 336 ALA A 339 -1 O ALA A 339 N PHE A 258 SHEET 1 AA2 3 GLU A 242 THR A 247 0 SHEET 2 AA2 3 GLY A 229 VAL A 236 -1 N PHE A 234 O PHE A 243 SHEET 3 AA2 3 GLY A 406 LYS A 409 -1 O GLN A 407 N ASN A 231 SITE 1 AC1 22 PHE A 246 THR A 247 THR A 248 ARG A 249 SITE 2 AC1 22 TYR A 327 VAL A 328 LEU A 329 TYR A 332 SITE 3 AC1 22 VAL A 337 MET A 338 HIS A 343 ASP A 344 SITE 4 AC1 22 THR A 373 LYS A 389 HOH A 606 HOH A 617 SITE 5 AC1 22 HOH A 643 HOH A 660 HOH A 686 HOH A 690 SITE 6 AC1 22 HOH A 696 HOH A 701 CRYST1 87.373 87.373 135.528 90.00 90.00 120.00 P 61 2 2 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011445 0.006608 0.000000 0.00000 SCALE2 0.000000 0.013216 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007379 0.00000